Home › NDC Lookup › RxCUI directory › RxCUI 1148249

Glycerin 2 MG/ML / hypromellose 3.6 MG/ML / polyethylene glycol 400 10 MG/ML / tetrahydroz... — RxCUI 1148249

Name: Glycerin 2 MG/ML / hypromellose 3.6 MG/ML / polyethylene glycol 400 10 MG/ML / tetrah… (RxCUI 1148249)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1148249 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1148249

Official nameGlycerin 2 MG/ML / hypromellose 3.6 MG/ML / polyethylene glycol 400 10 MG/ML / tetrahydrozoline hydrochloride 0.5 MG/ML / zinc sulfate 2.5 MG/ML Ophthalmic Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asglycerin 0.2 % / hypromellose 0.36 % / polyethylene glycol 400 1 % / tetrahydrozoline HCl 0.05 % / zinc sulfate 0.25 % Ophthalmic Solution; Glycerin 2 MG/ML / hypromellose 3.6 MG/ML / Polyethylene Glycol 400 10 MG/ML / Tetrahydrozoline hydrochloride 0.5 MG/ML / ZnSO4 2.5 MG/ML Ophthalmic Solution

FDA products mapped1

Package NDCs mapped1

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tetrahydrozoline Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It relieves the redness you see, but it doesn't treat the underlying cause of the irritation. Think of it as a short-term fix to take the red out. If something is genuinely botheri...
What exactly does this eye drop do — does it actually fix what's irritating my eye?
No — you should remove your contact lenses before putting in the drops. The solution can be absorbed by soft contacts, which can affect the lens and potentially irritate your eye....
Can I wear my contact lenses while using these drops?

📖 Read our full Tetrahydrozoline Ophthalmic guide →

🕸️ Concept Web — How Glycerin 2 MG/ML / hypromellose 3.6 MG/ML / poly... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Glycerin 2 MG/ML / hypromellose 3.6 MG/ML / polyethylene glycol 400 10 MG/ML / tetrahydrozoline hydrochloride 0.5 MG/ML / zinc sulfate 2.5 MG/ML Ophthalmic Solution RxCUI 1148249 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 7

The active substance itself — no strength, form, or brand attached yet.
- Glycerin 4910 IN
- Hypromellose 27334 IN
- Polyethylene glycol 400 8514 IN
- Tetrahydrozoline 37935 IN
- Zinc sulfate 39954 IN
- Glycerin / hypromellose / polyethylene glycol 400 / tetrahydrozoline / zinc sulfate 1007750 MIN
- Tetrahydrozoline hydrochloride 57983 PIN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Glycerin / hypromellose / polyethylene glycol 400 / tetrahydrozoline / zinc sulfate Ophthalmic Solution 968661 SCDF
- Glycerin / hypromellose / polyethylene glycol 400 / tetrahydrozoline hydrochloride / zinc sulfate Ophthalmic Solution 2646814 SCDFP
- Glycerin / hypromellose / polyethylene glycol 400 / tetrahydrozoline / zinc sulfate Ophthalmic Product 1156223 SCDG
- Glycerin / hypromellose / polyethylene glycol 400 / tetrahydrozoline hydrochloride / zinc sulfate Ophthalmic Product 2659929 SCDGP
- Ophthalmic Solution 7670 DF
- Ophthalmic Product 1151135 DFG
Clinical & branded drugs 5

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Glycerin 2 MG/ML 332045 SCDC
- Hypromellose 3.6 MG/ML 705817 SCDC
- Polyethylene glycol 400 10 MG/ML 336921 SCDC
- Tetrahydrozoline hydrochloride 0.5 MG/ML 996200 SCDC
- Zinc sulfate 2.5 MG/ML 328921 SCDC

Showing up to 8 concepts per family — 18 of 18 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Glycerin 2 MG/ML SCDC · 332045
Hypromellose 3.6 MG/ML SCDC · 705817
Polyethylene glycol 400 10 MG/ML SCDC · 336921
Tetrahydrozoline hydrochloride 0.5 MG/ML SCDC · 996200
Zinc sulfate 2.5 MG/ML SCDC · 328921
Glycerin / hypromellose / polyethylene glycol 400 / tetrahydrozoline / zinc sulfate Ophthalmic Solution SCDF · 968661
Glycerin / hypromellose / polyethylene glycol 400 / tetrahydrozoline hydrochloride / zinc sulfate Ophthalmic Solution SCDFP · 2646814
Glycerin / hypromellose / polyethylene glycol 400 / tetrahydrozoline / zinc sulfate Ophthalmic Product SCDG · 1156223
Glycerin / hypromellose / polyethylene glycol 400 / tetrahydrozoline hydrochloride / zinc sulfate Ophthalmic Product SCDGP · 2659929

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 1148249 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00363-1462-01	1 BOTTLE, DROPPER in 1 CARTON (0363-1462-01) / 15 mL in 1 B...	Walgreens Multi-Symptom Relief Eye Drops	Walgreen Co.	2020-03-06

Observed labelers: Walgreen Co. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.